The Canadian market has experienced a period of sideways consolidation over the past three months, which may act as a corrective force amidst ongoing policy uncertainty and trade worries. In such conditions, investors often seek diversification to balance their portfolios, and penny stocks can offer intriguing opportunities due to their affordability and potential for growth. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still provide value and growth prospects when backed by strong financials.
Name | Share Price | Market Cap | Financial Health Rating |
Alvopetro Energy (TSXV:ALV) | CA$4.72 | CA$172.56M | ★★★★★★ |
Findev (TSXV:FDI) | CA$0.50 | CA$14.32M | ★★★★★★ |
Mandalay Resources (TSX:MND) | CA$4.79 | CA$449.82M | ★★★★★★ |
PetroTal (TSX:TAL) | CA$0.69 | CA$632.31M | ★★★★★★ |
BluMetric Environmental (TSXV:BLM) | CA$0.97 | CA$35.81M | ★★★★★★ |
New Gold (TSX:NGD) | CA$3.93 | CA$3.11B | ★★★★★☆ |
NamSys (TSXV:CTZ) | CA$1.15 | CA$30.89M | ★★★★★★ |
Amerigo Resources (TSX:ARG) | CA$1.81 | CA$298.08M | ★★★★★☆ |
Foraco International (TSX:FAR) | CA$2.03 | CA$200.35M | ★★★★★☆ |
Orezone Gold (TSX:ORE) | CA$0.82 | CA$379.19M | ★★★★★☆ |
Click here to see the full list of 931 stocks from our TSX Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany with a market cap of CA$1.13 billion.
Operations: The company generates revenue of $117.62 million from its operations in cultivating, manufacturing, and marketing cannabis and cannabis-derived products.
Market Cap: CA$1.13B
Cronos Group has shown financial improvement, becoming profitable with a net income of US$41.08 million for 2024, reversing a previous year's loss. The company reported full-year revenue of US$117.62 million, indicating growth from the prior year. Despite earnings forecasted to decline by an average of 16.8% annually over the next three years, revenue is expected to grow by 10.53% per year. Cronos remains debt-free and its short-term assets significantly exceed liabilities, although its Return on Equity is low at 3.6%. The management team is experienced; however, the board lacks seasoned members.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Discovery Silver Corp. is a mineral exploration company focused on the exploration and development of polymetallic mineral deposits, with a market capitalization of CA$632.73 million.
Operations: Discovery Silver Corp. has not reported any revenue segments.
Market Cap: CA$632.73M
Discovery Silver Corp., a pre-revenue entity with a market cap of CA$632.73 million, maintains financial stability with no debt and short-term assets of CA$37.1 million exceeding liabilities. Despite being unprofitable and experiencing increased losses over the past five years, the company has secured a cash runway for over a year at current free cash flow levels. Recent developments include raising CAD 225 million through equity offerings to support its acquisition strategy, notably the Porcupine Complex in Ontario. Management is experienced with an average tenure of 2.2 years, while its board averages 6.7 years in tenure.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Royal Road Minerals Limited is involved in the exploration and development of mineral properties across Saudi Arabia, Morocco, Colombia, and Nicaragua with a market cap of CA$30.56 million.
Operations: Royal Road Minerals Limited has not reported any specific revenue segments.
Market Cap: CA$30.56M
Royal Road Minerals Limited, with a market cap of CA$30.56 million, is pre-revenue and currently unprofitable. The company maintains financial stability with short-term assets of CA$10.5 million surpassing both its short-term liabilities of CA$208.7K and long-term liabilities of CA$11.6K, while being debt-free enhances its financial resilience. Its cash runway extends over three years based on current free cash flow levels, providing a buffer for ongoing operations despite historical losses increasing at 25.6% per year over the past five years. Management and board members are experienced, averaging tenures of 4.3 and 3.3 years respectively.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TSX:CRON TSX:DSV and TSXV:RYR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。